These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

736 related items for PubMed ID: 15144854

  • 21. Ubiquitination of alpha-synuclein.
    Nonaka T, Iwatsubo T, Hasegawa M.
    Biochemistry; 2005 Jan 11; 44(1):361-8. PubMed ID: 15628878
    [Abstract] [Full Text] [Related]

  • 22. Antiapoptotic property of human alpha-synuclein in neuronal cell lines is associated with the inhibition of caspase-3 but not caspase-9 activity.
    Li W, Lee MK.
    J Neurochem; 2005 Jun 11; 93(6):1542-50. PubMed ID: 15935070
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Sensitive fluorescence polarization technique for rapid screening of alpha-synuclein oligomerization/fibrillization inhibitors.
    Luk KC, Hyde EG, Trojanowski JQ, Lee VM.
    Biochemistry; 2007 Nov 06; 46(44):12522-9. PubMed ID: 17927212
    [Abstract] [Full Text] [Related]

  • 25. A strategy for designing inhibitors of alpha-synuclein aggregation and toxicity as a novel treatment for Parkinson's disease and related disorders.
    El-Agnaf OM, Paleologou KE, Greer B, Abogrein AM, King JE, Salem SA, Fullwood NJ, Benson FE, Hewitt R, Ford KJ, Martin FL, Harriott P, Cookson MR, Allsop D.
    FASEB J; 2004 Aug 06; 18(11):1315-7. PubMed ID: 15180968
    [Abstract] [Full Text] [Related]

  • 26. Altered ion channel formation by the Parkinson's-disease-linked E46K mutant of alpha-synuclein is corrected by GM3 but not by GM1 gangliosides.
    Di Pasquale E, Fantini J, Chahinian H, Maresca M, Taïeb N, Yahi N.
    J Mol Biol; 2010 Mar 19; 397(1):202-18. PubMed ID: 20114052
    [Abstract] [Full Text] [Related]

  • 27. Neuropathology of primary restless leg syndrome: absence of specific tau- and alpha-synuclein pathology.
    Pittock SJ, Parrett T, Adler CH, Parisi JE, Dickson DW, Ahlskog JE.
    Mov Disord; 2004 Jun 19; 19(6):695-9. PubMed ID: 15197711
    [Abstract] [Full Text] [Related]

  • 28. Protective effect of TAT-delivered alpha-synuclein: relevance of the C-terminal domain and involvement of HSP70.
    Albani D, Peverelli E, Rametta R, Batelli S, Veschini L, Negro A, Forloni G.
    FASEB J; 2004 Nov 19; 18(14):1713-5. PubMed ID: 15345691
    [Abstract] [Full Text] [Related]

  • 29. Synphilin-1 associates with alpha-synuclein and promotes the formation of cytosolic inclusions.
    Engelender S, Kaminsky Z, Guo X, Sharp AH, Amaravi RK, Kleiderlein JJ, Margolis RL, Troncoso JC, Lanahan AA, Worley PF, Dawson VL, Dawson TM, Ross CA.
    Nat Genet; 1999 May 19; 22(1):110-4. PubMed ID: 10319874
    [Abstract] [Full Text] [Related]

  • 30. Inhibition of alpha-synuclein fibrillization by dopamine analogs via reaction with the amino groups of alpha-synuclein. Implication for dopaminergic neurodegeneration.
    Li HT, Lin DH, Luo XY, Zhang F, Ji LN, Du HN, Song GQ, Hu J, Zhou JW, Hu HY.
    FEBS J; 2005 Jul 19; 272(14):3661-72. PubMed ID: 16008565
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Agrin binds alpha-synuclein and modulates alpha-synuclein fibrillation.
    Liu IH, Uversky VN, Munishkina LA, Fink AL, Halfter W, Cole GJ.
    Glycobiology; 2005 Dec 19; 15(12):1320-31. PubMed ID: 16037493
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Low frequency of alpha-synuclein mutations in familial Parkinson's disease.
    Farrer M, Wavrant-De Vrieze F, Crook R, Boles L, Perez-Tur J, Hardy J, Johnson WG, Steele J, Maraganore D, Gwinn K, Lynch T.
    Ann Neurol; 1998 Mar 19; 43(3):394-7. PubMed ID: 9506559
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Heat shock prevents alpha-synuclein-induced apoptosis in a yeast model of Parkinson's disease.
    Flower TR, Chesnokova LS, Froelich CA, Dixon C, Witt SN.
    J Mol Biol; 2005 Sep 02; 351(5):1081-100. PubMed ID: 16051265
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Gene dosage and pathogenesis of Parkinson's disease.
    Eriksen JL, Przedborski S, Petrucelli L.
    Trends Mol Med; 2005 Mar 02; 11(3):91-6. PubMed ID: 15760766
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Generation of a alpha-synuclein-based rat model of Parkinson's disease.
    Recchia A, Rota D, Debetto P, Peroni D, Guidolin D, Negro A, Skaper SD, Giusti P.
    Neurobiol Dis; 2008 Apr 02; 30(1):8-18. PubMed ID: 18313315
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 37.